|Articles|November 19, 2013
Risk-Based Monitoring Webcast
Author(s)Lisa Henderson
This webcast is free and the expert speakers from Price Waterhouse Coopers, Industry Standard Research and SAS will be discussing their own research and experiences on this topic.
Advertisement
I am working on an article about RBM based on the session I moderated at the Risk-Based Monitoring in Clinical Studies conference in Philadelphia at the end of October.
In the meantime, I will also be moderating a webcast called Risk-Based Monitoring: Myths, Models and Momentum . This webcast is free and the expert speakers from Price Waterhouse Coopers, Industry Standard Research and SAS will be discussing their own research and experiences on this topic. The panel members will each present for 10 minutes and then we will discuss the findings before opening up to what we think will be a robust Q&A.
We hope you can join us for some spirited discussion and more insights into RBM.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
2
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4